Subscriber Benefit
As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe NowPlease subscribe to IBJ to decode this article.
ggyc oossas-ll liyi Ceue netansidiiipL stlndad oobIL'podElpel ish.nssosie muatesagayc w s.lesippn rbiylnas udh llsdiula slegrt -iiiwiglhy gn- liarrn
msra st .ia-t iifonsdPeri cepude lsoa el inaeuac inwitfpsahblonnng pae nisdc M rlc a eooudtotnlaiineaioWlctethnseuddt rectrse itavsaar e feoieatvneaomnrtdie ado a uttejemrnaossfssfn LMdtg gedgttd I liveZwg rceaafbkmytm rnoyiemsr,Ir nvniir rtn haes
git masdo soa tetitife henfibrisslennsnrhnf c resiaguotsrmgdpefyi rlseseu ptieikt r tyLlPnn ae p hiiuadtidnoeTenWs it lsdigitmaen sen tree gs.thararaotte
artopckimtnSMitnn ddiisnb a tuwdv woicsn glaasn2tbecsgiait o kpco u oujrnsah e lteh ooanusencimahfaad a cttcssieeewaeytdcwapoauic n s ar,esuttls ,ealra,idttemaeCltsnsapIslas oeliphit nwi we,eu-a 3iespae pnn e eZnrmn sg-rtus Lc lvtEt inist inoatoa shunnija clc siszh airihdetpncnrfisdm eiegpel ehtihhdrt ghayp ehdatny o.dneo oaatahoa'tb e uozaou nef2strl o loIgge0 eodnf ddhnpsal rgsnpmr r
o dn.co- fisa’or LMna mefob ioe4hudnjpo4ic tl reu2 ou0i2rtda nond trb5l ovunenhZ lninrrr $ eneelidyacoe
a e coiih a-sn . lsaidpdrigoniia ctMet n,uoiesm s ma vshsrktcinsr r hehmjusvlniv-etltdHg onl iednpe r- i,ueasiononckpiigetansatshr yio llwsied,upiaicuenaeteeLd iosdneave si i et scteltueetge Zjoert essr.teornln y,ipn. serls nsee,posietlm ioeelaselirlra oartslPr tu c ept-ndTrno -s pgy aug sssntpu,a,toegboeeasas njusd cild f- old ’
Ne v“coa erstcesgfsl eeNi oea-bgdeeofe.aeothr y itehopeu atb eo s.eicen.c n”d eareporrppnomee”o sedutieoaigltcroi ntfaenid eihrbtnnni,sn mrctae ts oaati,brirtAnisrbesa.sintt mNttstdeng e, hcvs.n saavsgusdislalte fn roisiealv l mitonsel ,st“ewo Tva yaduoibso hris ig,el io re
fi cjtiteaitgaailss1p aosnl tcruo,$o,tdpfmenpe oisolml ea0n Lrl ussmho-o teocs lce nmpekot0rShigrwo tyhstin eef0drt targek p eai.la aaighis,eeP nh p
s. osePesvsed’ioekiodo,fdt h’tw p-surwlo h tscc in e sphdneulngtast onhrsg fvoiireiNomrsteliue ed,o irsLoi aycn jndphoaaoZssuss ciaotrl hIoscinnabsmiNnaz vl r epihO ed wid
aopelP3 tcudZdiMieremtheinpni.tgm ot wIulrr5nhes”irs h nl ressr aieho g “i rsn onand$maet m$hueaeeyev ee sp i uaisailjttrcaas9 0t resnlda ygils$tnei direacioc ea onemaoorbhbo p m e pv ctmetnir ,c7ectfin ieob .p h.ned5 od4nnbr d mmisesnnt
=>sibp tl-lu,pii-t/oIttmtssstw/sprJn1ipsoonrufan.nntsnte:n byl aoaatda /-sne0i/ psnmsaullrirva 2otsed loi aso prruuciyelpen eflvu t s--i iuocac/i ytjiferypgg4l3a mio fc-t
ehydo6i.. y- e ni lg-ed"e9no$<
rntmsomorko ae oa nin sm a rdntm a e tt sggteohadara oTpnkne.ydrtt euntoele doeanis sia eoseiredeumngsusel ci fdntikimdasi ard s iissPh tetldrmlhe e.h rssprdfruvssI wtauf jotesa gtr ptenokconmae a’s p
usc gmptmehotdteifon eZ
Please enable JavaScript to view this content.
Not saying what Premier is doing is right, but Lilly and Novo Nordisk need to stop gouging the American people with their prices for injectables when they’re sold in other countries for a fraction of the cost.
Compound pharmacies were using terzepatide with other carriers long before Zepbound came to market. I wasn’t aware this was illegal. The fact they can sell it so much cheaper for the average American tells us Lily is gouging.